Preliminary study results examining the bispecific antibody, CDK4/6 inhibitor and hormone therapy combination in patients with advanced breast cancer were presented at SABCS. Treatment with bispecific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results